miRNA-181a联合生物电阻抗相位角预测男性头颈癌患者放疗引起的身体成分变化与生存
该研究探讨生物电阻抗相位角(PA)联合miRNA-181a表达预测头颈癌患者放疗(RTH)引起的身体成分变化。同时存在低PA和高miRNA表达的患者,其去脂体重指数(FFMI)<14.9 kg/m²、去脂体重(FFM)<44.7 kg及瘦体重下降的风险显著更高,且生存受到负面影响。PA联合miRNA评估对检测RTH引起的身体成分变化具有更高的诊断准确性和预测价值。
要点
- 低PA且高miRNA-181a表达者FFMI<14.9 kg/m²风险OR=5.14(P=.02)。
- 该联合指标预测FFM<44.7 kg的OR=6.20(P=.04),瘦体重下降OR=10.0(P=.04)。
- 高miRNA且低PA同时存在对生存有负面影响(OR=5.12;P=.02)。
核心结论
- PA联合miRNA评估对检测RTH引起的癌症患者身体成分变化具有更高的诊断准确性和预测价值。
- 同时存在低PA和高miRNA表达的患者在治疗期间去脂体重指数、去脂体重和瘦体重下降的风险显著更高,且生存受到负面影响。
研究设计与样本
- 研究纳入接受放疗的头颈癌男性患者,评估生物电阻抗相位角(PA)联合miRNA-181a表达对放疗引起身体成分变化及生存的预测价值。
主要发现
- 同时存在低PA和高miRNA表达的患者,去脂体重指数(FFMI)<14.9 kg/m²的风险显著更高(OR=5.14;P=.02)。
- 同时存在低PA和高miRNA表达的患者,去脂体重(FFM)<44.7 kg的风险显著更高(OR=6.20;P=.04)。
- 同时存在低PA和高miRNA表达的患者,瘦体重下降的风险显著更高(OR=10.0;P=.04)。
- 受试者工作特征曲线分析可预测FFMI、瘦体重和FFM的变化,曲线下面积计算值超过0.700。
- 同时存在高miRNA和低PA对患者生存有负面影响(OR=5.12;P=.02)。
关键数值与推荐
- 低PA且高miRNA表达者FFMI<14.9 kg/m²的OR=5.14(P=.02)。
- 低PA且高miRNA表达者FFM<44.7 kg的OR=6.20(P=.04)。
- 低PA且高miRNA表达者瘦体重下降的OR=10.0(P=.04)。
- 高miRNA且低PA者生存的OR=5.12(P=.02)。
- 预测FFMI、瘦体重和FFM变化的曲线下面积计算值超过0.700。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nutritional deficits developing as an effect of applied radiotherapy (RTH) negatively affect patients' quality of life, survival, and therapy outcomes. We demonstrated novel approach to prediction of RTH-induced changes in body composition of patients with head and neck cancer using phase angle (PA) derived from bioelectrical impedance in combination with miRNA-181a expression. RESULTS: Patients with simultaneous presence of low PA and high miRNA expression were at a significantly higher risk of decreasing the fat-free mass index (FFMI) <14.9 kg/m2 (odds ratio [OR] = 5.14; P = .02), FFM < 44.7 kg (OR = 6.20; P = .04), and lean mass (OR = 10.0; P = .04) during the therapy period. Receiver operating curve analysis allowed to predict changes in FFMI, lean mass, and FFM with area under the curve calculation over 0.700. The simultaneous presence of high miRNA and low PA negatively affected patients' survival (OR = 5.12; P = .02). CONCLUSION: Evaluation of PA in combination with miRNA demonstrates higher diagnostic accuracy and predictive value for detecting RTH-induced changes in body composition of patients with cancer.
引用
- Powrózek T, Brzozowska A, Mazurek M, et al. Combined analysis of miRNA-181a with phase angle derived from bioelectrical impedance predicts radiotherapy-induced changes in body composition and survival of male patients with head and neck cancer. Head Neck. 2019. PMID: 31165544. doi:10.1002/hed.25830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。